Octavian Bucur
Associate Investigator, Resident Member

MD, PhD trained in Molecular and Computational Pathology, Molecular Oncology, Biomedical Technology Development. MD from Carol Davila University, Bucharest, the leading medical school from Romania; PhD in Biochemistry/Biology from Romanian Academy with work and training performed at Harvard Medical School/BIDMC.

Over a decade of training and research at Harvard Medical School: Postdoctoral Fellow at BIDMC and Harvard Medical School, Instructor in Pathology (Faculty), Harvard Medical School (2017-2018); Associate Member, Wyss Institute of Biologically Inspired Engineering at Harvard (2014-2015), Associate Member of the Ludwig Cancer Center at Harvard University, Boston, MA (2016-2018), affiliated with Broad Institute of MIT and Harvard, Boston, MA (2016-2018).

Dr. Octavian Bucur has made impactful contributions in several research fields, being one of the main developers of Expansion Pathology (Nature Biotechnology 2017 (in the top 5% of all research outputs scored by Altmetric), Nature Protocols 2020; 3 patents). This method extends the current resolution limit (250 nm) of the optical microscopes to 70 nm, enabling visualization of smaller nanoscopic structures with inexpensive optical microscopy in preserved tissue specimens, after physical tissue expansion. Expansion-related technologies have tremendous implications in several biomedical fields, including diagnostic pathology, neuroscience and molecular medicine.

Among the honors and awards received over the years are: Recognition of Outstanding Achievement in Translational and Basic Science Research from the Harvard Medical School Pathology Department; ranked 1st out of >100 - Best Scientific Poster Award (2017, Harvard Medical School Pathology Retreat of MGH, BIDMC, BWH, DFCI, Children’s Hospital Boston); The American Association for Cancer Research (AACR)-Millennium Pharmaceuticals Award (2015, Philadelphia, PA), IUBMB Travel Fellowship (2010, Melbourne, Australia), The American Association for Cancer Research (AACR)-Aflac Award (2008, San Diego, CA); Lady Tata Memorial Trust International Award for Leukemia Research (2007, London, UK); European Union - Leonardo da Vinci Research Award (2004, Magdeburg, Germany); Invited Keynote Speaker/Special Lectures (conferences in San Francisco, Chicago, London (UK), Bucharest  (Romania), BIDMC, Harvard Medical School - Boston, Wayne State University - Detroit, Carol Davila University, Romania); Chair of the Scientific Selection Committee for the RALI's Grand Rounds competition, Research Assistant Learning Initiative, Boston (2017-2018); Invited Judge for many undergraduate/graduate research competitions; International grant evaluator.

Dr. Octavian Bucur is a Co-Founder, major stakeholder and was the first CEO of Viron Therapeutics, Boston, MA and QPathology, Boston, MA. He is the Editor in Chief of the journal Discoveries (PubMed and PMC indexed in 2019/09): https://www.ncbi.nlm.nih.gov/pmc/journals/3713/  



LATEST NEWS

Octavian presented a Keynote Lecture at the 10th Drug Discovery Strategic Summit - October 28, 2022

Octavian mentored 2 teams that competed in the Hackathon4Health, both winning 2 of the 3 main prizes - October 29th, 2022, Bucharest, Romania

Octavian was invited at the Romanian National Television - TVRi (Viron News) - October 31, 2022

January 2023:  Invited Speaker, Beth Israel Deaconess Medical Center (Harvard Medical School affiliated hospital), BIDMC Postdoctoral Association and BPDA, Boston, MA, USA


Upcoming invitations (Expansion Pathology, Machine Learning in Pathology)

April 2023: Invited Keynote Speaker - 20th Conference on Breast Pathology & Cancer Diagnosis, Montreal, Canada

April 2023: Invited Speaker - STOP Cancer, Bucharest, Romania

April 2023: Invited Plenary Speaker - Global Pharma & Drug Delivery Summit 2023, Frankfurt, Germany

May 2023: Invited Keynote Speaker - 12th Drug Discovery Strategic Summit, Boston, MA, USA